United States · FDA National Drug Code directory
Alfuzosin hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63629-9155_f10b905b-346c-493f-ad51-54c0b9e0d3a4
- Product NDC
- 63629-9155
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Alfuzosin hydrochloride
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160315
- Source listing expiry
- 20261231
Source-listed ingredients
- ALFUZOSIN HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63629-9155-1) · 63629-9155-1
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63629-9155-2) · 63629-9155-2
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63629-9155-3) · 63629-9155-3
- 120 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63629-9155-4) · 63629-9155-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →